BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 38492056)

  • 1. Ultra-High Mass Resolution MALDI Imaging Mass Spectrometry of Proteins and Metabolites in a Mouse Model of Glioblastoma.
    Dilillo M; Ait-Belkacem R; Esteve C; Pellegrini D; Nicolardi S; Costa M; Vannini E; Graaf EL; Caleo M; McDonnell LA
    Sci Rep; 2017 Apr; 7(1):603. PubMed ID: 28377615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatially resolved distribution of pancreatic hormones proteoforms by MALDI-imaging mass spectrometry.
    Sisnande T; Brum FL; Matias DO; de Sá Ribeiro F; Moulin TB; Mohana-Borges R; de Magalhães MTQ; Lima LMTR
    Anal Biochem; 2024 Sep; 692():115570. PubMed ID: 38763320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing mass spectrometry imaging accessibility using convolutional autoencoders for deriving hypoxia-associated peptides from tumors.
    Bitto V; Hönscheid P; Besso MJ; Sperling C; Kurth I; Baumann M; Brors B
    NPJ Syst Biol Appl; 2024 May; 10(1):57. PubMed ID: 38802379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of MALDI-MS/MS-Based Proteomics in Biomedical Research.
    Darie-Ion L; Whitham D; Jayathirtha M; Rai Y; Neagu AN; Darie CC; Petre BA
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-MALDI MS and MS/MS--an efficient tool in proteome analysis.
    Mueller DR; Voshol H; Waldt A; Wiedmann B; Van Oostrum J
    Subcell Biochem; 2007; 43():355-80. PubMed ID: 17953403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.
    Li CMY; Briggs MT; Lee YR; Tin T; Young C; Pierides J; Kaur G; Drew P; Maddern GJ; Hoffmann P; Klingler-Hoffmann M; Fenix K
    Clin Exp Med; 2024 Mar; 24(1):53. PubMed ID: 38492056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of MALDI Imaging Proteolytic Peptides Using LC-MS/MS-Based Biomarker Discovery Data: A Proof of Concept.
    Longuespée R; Ly A; Casadonte R; Schwamborn K; Kazdal D; Zgorzelski C; Bollwein C; Kriegsmann K; Weichert W; Kriegsmann J; Schirmacher P; Fresnais M; Oliveira C; Kriegsmann M
    Proteomics Clin Appl; 2019 Jan; 13(1):e1800158. PubMed ID: 30525291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein identification by accurate mass matrix-assisted laser desorption/ionization imaging of tryptic peptides.
    Schober Y; Schramm T; Spengler B; Römpp A
    Rapid Commun Mass Spectrom; 2011 Sep; 25(17):2475-83. PubMed ID: 21818808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically-assisted fragmentation combined with multi-dimensional liquid chromatography and matrix-assisted laser desorption/ionization post source decay, matrix-assisted laser desorption/ionization tandem time-of flight or matrix-assisted laser desorption/ionization tandem mass spectrometry for improved sequencing of tryptic peptides.
    Flensburg J; Tangen A; Prieto M; Hellman U; Wadensten H
    Eur J Mass Spectrom (Chichester); 2005; 11(2):169-79. PubMed ID: 16046801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal calibrants allow high accuracy peptide matching between MALDI imaging MS and LC-MS/MS.
    Gustafsson JOR; Eddes JS; Meding S; Koudelka T; Oehler MK; McColl SR; Hoffmann P
    J Proteomics; 2012 Aug; 75(16):5093-5105. PubMed ID: 22634080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone modification: Biomarkers and potential therapies in colorectal cancer.
    An X; Lan X; Feng Z; Li X; Su Q
    Ann Hum Genet; 2023 Nov; 87(6):274-284. PubMed ID: 37712180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and gender perspectives in colorectal cancer.
    Baraibar I; Ros J; Saoudi N; Salvà F; García A; Castells MR; Tabernero J; Élez E
    ESMO Open; 2023 Apr; 8(2):101204. PubMed ID: 37018873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming.
    Zhang Q; Cui K; Yang X; He Q; Yu J; Yang L; Yao G; Guo W; Luo Z; Liu Y; Chen Y; He Z; Lan P
    Clin Transl Med; 2023 Jan; 13(1):e1164. PubMed ID: 36629054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.
    Morgan E; Arnold M; Gini A; Lorenzoni V; Cabasag CJ; Laversanne M; Vignat J; Ferlay J; Murphy N; Bray F
    Gut; 2023 Feb; 72(2):338-344. PubMed ID: 36604116
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.